Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets (2013)
- Authors:
- USP affiliated authors: FERREIRA, MARCUS CASTRO - FM ; SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF
- Unidades: FM; FCF
- DOI: 10.1016/j.burns.2012.07.005
- Subjects: QUEIMADURAS (TERAPIA); ESTUDOS PROSPECTIVOS; CRIANÇAS; ANTIBIÓTICOS (USO TERAPÊUTICO)
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GOMEZ, David S. et al. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets. Burns, v. 39, n. 3, p. 445-450. 2013, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.burns.2012.07.005. Acesso em: 28 jan. 2026. -
APA
Gomez, D. S., Campos, E. V., Azevedo, R. P. de, Silva-Jr, J. M. da, Ferreira, M. C., Sanches-Giraud, C., et al. (2013). Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets. Burns, 39( 3), 445-450. 2013. doi:10.1016/j.burns.2012.07.005 -
NLM
Gomez DS, Campos EV, Azevedo RP de, Silva-Jr JM da, Ferreira MC, Sanches-Giraud C, Silva-Jr CV, Santos SRCJ. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets [Internet]. Burns. 2013 ; 39( 3): 445-450. 2013.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1016/j.burns.2012.07.005 -
Vancouver
Gomez DS, Campos EV, Azevedo RP de, Silva-Jr JM da, Ferreira MC, Sanches-Giraud C, Silva-Jr CV, Santos SRCJ. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets [Internet]. Burns. 2013 ; 39( 3): 445-450. 2013.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1016/j.burns.2012.07.005 - Ciprofloxacin, oxacillin, piperacillin and sulfamethoxazole by systemic administration for the control of severe infections: is dose adjustment required for critical burn patients?
- Vancomycin dose adjustment in severe burn patients based on trough level for drug effectiveness against pathogens at 1 mg/l minimum inhibitory concentration
- Imipenem serum measurements in real time for target attainment against more agressive strains MlC>2mg/l in septic burns
- Vancomycin prescription changes in real time based on drug plasma monitoring against Staphylococcus spp MlC 2mg/l in critically ill paediatric burns
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
- Vancomycin effectiveness by PK/PD correlation in burn patients
- PK/PD correlation for imipenem effectiveness in burn patients
- PK/PD correlation of vancomycin for dose adjustment for the control of infections in pediatric critical burn patients
- Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic
- Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics?
Informações sobre o DOI: 10.1016/j.burns.2012.07.005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
